Use of Flt3 Ligand for Strengthening Immune Responses in Rna Immunization
The invention relates to supplying vaccine RNA to cells. The invention relates in particular to a common use of vaccine RNA and Flt3 ligand for inducing, creating or enhancing an immune response when administered to animals (including humans).
Attached files:Patents:WO 2,010,066,418 [
MORE INFO]
Inventor(s):
SAHIN UGUR [DE]; TUERECI OEZLEM [DE]; KREITER SEBASTIAN [DE]
Type of Offer:
Sale
« More Medical Patents